Eli Lilly and Company
DNA molecules encoding anti-IL-33 antibodies
Last updated:
Abstract:
Antibodies which bind and neutralize human IL-33, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with allergic disease including treating atopic dermatitis.
Status:
Grant
Type:
Utility
Filling date:
25 Oct 2019
Issue date:
9 Feb 2021